Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma

Now, a group of scientists at Children's Hospital Los Angeles have developed a modified version of CAR T that shows promise in targeting neuroblastoma, spares healthy brain tissue and more effectively kills cancer cells.

Read more: https://www.news-medical.net/news/20210122/Modified-version-of-CAR-T-cell-therapy-shows-promise-in-targeting-neuroblastoma.aspx